KARD — Kardigan, Inc. catalysts
Next verified catalyst
2026-12-01 — Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 4mo
ESTIMATED |
READOUT
Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospit
Phase 2 · Hypertension, Acute Severe Hypertension |
KARD Kardigan, Inc. | Tonlamarsen |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|